Nasogastric Tube Market Size, Share & Trends Analysis Report By Product (Levin Tube & Sengstaken-Blakemore Tube), By Applications (Children Use, Adult Use), By End Use, By Region, and Segment Forecasts - 2035

NASOGASTRIC TUBE MARKET OVERVIEW

The global nasogastric tube market size was valued at USD 272.56 million in 2025 and is projected to grow from USD 280.19 million in 2026 to USD 304.39 million by 2035, exhibiting a CAGR of 2.8% during the forecast period.

The nasogastric tube market is a critical section of the medical device sector whose products are aimed at patients with low ability to consume food due to their medical state or other factors. These are tubes that are passed through the nasal tract to the stomach; they are used for feeding, giving medication, and helping with gastric pump potassium. The drivers include new and more frequent cases of chronic diseases, improvements in technologies related to the use of tubes, and growing need for homecare-related products. With the increasing focus on patient-centred care by caregivers in the treatment of critical illnesses, the global market for the NASOGASTRIC TUBE is projected to grow at a fast pace because of new products and applications in clinical use.

The United States represents one of the largest users of nasogastric tubes due to its advanced acute-care infrastructure, with more than 6,100 hospitals and over 920,000 staffed hospital beds supporting enteral nutrition services. More than 58 million adults in the country are aged 65 years or older, increasing demand for short-term feeding solutions in hospitals and home healthcare. Stroke affects approximately 795,000 Americans annually, while over 2 million new cancer cases are diagnosed each year, creating consistent clinical demand for nasogastric tube placement. Widespread adoption of ENFit-compatible connectors, strong FDA regulatory oversight, and increasing use of polyurethane and silicone tubes continue to strengthen product utilization across U.S. healthcare facilities.

• • 

    Download Free sample to learn more about this report.

KEY FINDINGS

• Market Size and Growth: The Nasogastric Tube Market size was USD 265.13 Million in 2024, is projected to grow to USD 270.91 Million by 2025 and exceed USD 288.03 Million by 2033, with a CAGR of 2.8%.

• Key Market Driver: Rising rates of chronic illness and gastrointestinal disorders are pushing demand—over 40 million Americans suffer from digestive diseases, often requiring nutritional or medication delivery support.

• Major Market Restraint: Patient discomfort and risk of complications remain challenges—studies suggest up to 15% of patients may experience nasal injury or aspiration pneumonia with long-term use.

• Emerging Trends: Silicone and polyurethane-based tubes are gaining popularity for their flexibility and reduced irritation; polyurethane tubes accounted for more than 35% of all hospital use in 2023.

• Regional Leadership: North America continues to lead, with the U.S. alone accounting for over 30% of global usage due to a high elderly population and better ICU infrastructure.

• Competitive Landscape: More than 25 global and regional players operate in this space, with names like Cardinal Health, B. Braun, and Medtronic offering diversified nasogastric tube lines.

• Market Segmentation: The fine-bore tube segment is widely used in hospitals for enteral feeding, making up nearly 45% of total clinical applications by volume in 2023.

• Recent Development: In 2024, a new low-friction coating technology by Boston Medical Technologies was launched, aimed at reducing insertion trauma and patient rejection rates by up to 20%.

COVID-19 IMPACT

"Nasogastric Tube Industry Had a positive Effect Due to Enhanced Focus during COVID-19 Pandemic"

The Global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic also positively impacted the growth of the market, mainly because of the rising demand for the nasogastric tubes that support nutrition in serious cases. Hospitals saw increased admissions and more acuity, with significantly increased dependence on enteral feeding systems. Also, COVID boosted trends about telemedicine and home care, which generated possible uses of the nasogastric tubes in outpatient services. In general, COVID-19 highlighted the role of nasogastric tubes in patient care, which helped the market maintain a positive trend during the crisis.

LATEST TREND

"Innovative trends enhance comfort and drive market growth"

Some trends are present in the market for the nasogastric tube. Some of these trends are developing highly needed innovative and user-friendly tubes that would provide comfort and ease to the patient. An interesting trend is the use of smart biomaterials in the design of medical devices, including biocompatible and antimicrobial coatings that cut the chances of infection. There is also a shift toward using technology-supported solutions for continuous assessment of the NASOG®’s patient population to guarantee specific and appropriate treatment. These trends are as follows and, taken together, denote a new understanding and appreciation for increasing patient satisfaction and the patient experience in medical environments.

NASOGASTRIC TUBE MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Levin Tube & Sengstaken-Blakemore Tube

• Levin Tube: A Levin tube is a type of NGT that is mostly used for purposes of aspiration of stomach content and enteral nutrition to a patient who cannot take foods through the mouth. Its design has one lumen where the food stuffs in the stomach can be suctioned and, at the same time, some medication or nutrients can be passed through the same channel. Being simple and versatile, Levin tubes are used in both hospital practice and home care practice.

• Sengstaken-Blakemore Tube: The Sengstacke-Blakemore tube is a particular kind of nasogastric tube used mainly for control of variceal haemorrhage in patients with liver disease. Some of the many lumens include an inflatable balloon, which compresses the oesophagus to control haemorrhage. Despite its importance, especially in emergencies, it is rather tricky, and its use should be closely monitored and a lot of attention should be paid to its placement.

By Application

Based on Application, the global market can be categorized into Children Use & Adult Use

• Children Use: People in the paediatric ward use nasogastric tubes for feeding, medications, and when the child has problems swallowing or a medical condition such as cancer that requires enteric support. Different precautions are employed when administering nasogastric tubes for pediatric patients, whereby most are shorter and softer to reduce any harm related to the procedure. Nasogastric tubes require proper attention to be paid by health care givers while managing, especially in children.

• Adult Use: It is used in the administration of food and medication and for drainage of the stomach in the treatment of various illnesses in adult patients who may be on surgery or patients with chronic ailments. Now it turns into non-straining, long-term management if desired or into short-term treatment depending on the need and state of the patient. Hence, based on the NASOGASTRIC TUBES flexibility in adult care units, there should be a focus on promoting its utility to the patients as well as the general schema of health improvement.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factor

"Geriatric population growth drives demand and market growth "

The growth in the geriatric population, rising number of chronologically ill patients, and mounting cases of neurological disorders, cancer, and gastrointestinal diseases will boost the growth of the nasogastric tube market. The patients are usually on prolonged nutritional support, which can be offered by nasogastric tubes. With healthcare being in a constant strive to provide better patient care, customers for these tubes remain in demand which leads to Nasogastric Tube Market Growth.

"Technological advancements enhance comfort and drive market growth"

The role of technology is proven effective as new softer tube material and other techniques for the insertion of the nasogastric tube also have a large contribution to the market. These improvements make for better and more comfortable patient conditions and decrease complications of tube insertion. Thus, the development of these improved products will make healthcare providers embrace the market even further.

Restraining Factor

"Complications from nasogastric may hinder market growth opportunities"

Another major limitation with regard to the use of the nasogastric tubes is that the procedure can be accompanied by complications risks including nasal discomfort, sinus infection, and sore throat, as well as erosion of the esophagus. These complications result in patient discomfort and may predispose the patient to the likelihood of having the tube replaced or removed. These risks may influence the benefits-risks ratio in which healthcare providers are likely to make some type of decision about the utilized nasogastric tube within clinical practice.

Opportunity

"Shift to home healthcare creates opportunities for nasogastric market growth"

One of the biggest opportunities in the current market is linked with the trend observed in a number of countries about the shift towards home healthcare. If people are spending more time at home as they recover from sickness or surgery or due to the management of their chronic diseases, then they need nutritional support solutions that are most effective and safe. This shift ensures the establishment of user-friendly nasal-gastric tube products to effectively control the patient needs by the caregivers. Manufacturers can improve the benefit of their products by targeting this growing market segment to take advantage of the growing adoption of home-based care.

Challenge

"Strict regulations and quality requirements may impede market growth"

The market for the nasogastric tubes faces a major problem: the complex and strict regulation and quality requirements set by the applicable health authorities. Companies are told to be at their best when it comes to the regulation of their products in the market; this makes the process time-consuming due to multiple legal formalities that are involved during the development of a product. Furthermore, the quality of products must be kept constant while introducing new products into the market, which can become difficult and may slow market development. This makes it very crucial for the companies to establish a proper quality management system and legal advice to survive.

• • 

    Download Free sampleto learn more about this report.

•  

NASOGASTRIC TUBE MARKET REGIONAL INSIGHTS

North America

North America has the largest market share for nasogastric tubes, mainly attributed to its developed healthcare system, high incidences of chronic diseases, and substantial spending on health care technology. The endoscope provides newly for the analysis of the nasogastric tube market, especially for the United States nasogastric tubes market, due to the continuous growth in the hospital and home care sectors. Moreover, development of new tubes and advanced healthcare equipment and instruments with a large number of players in the global market are the major factors coming in favor of market growth. This sound structure helps North America to continue to dominate the global nasogastric tube market.

Europe

European region plays a remarkable role in the development of the nasogastric tubes markets due to its elaborate health care facilities and the increasing elderly population, which requires sophisticated nutrition intervention solutions. Another feature of the region is the emphasis on research activities contributing to such values for new products as patient comfort and safety. Further, an application of proper measures in the medical device industry guarantees quality assurance, therefore upholding the providers confidence in the medical devices. Therefore, the European agreement on enhancing the information technologies relating to healthcare positions.

Asia

Asia is a part of the nasogastric tube market through fast economic growth, higher healthcare spending, and growing consciousness of sophisticated technologies among the population. Demand for nutritional support solutions, especially in the large and demographically diverse population in the region, is fueled by the high incidence of chronic diseases in the nations. Also driving the market is growth in more healthcare facilities and in the government’s endeavors to enhance access to healthcare. Therefore, exotic markets in Asia are being identified as major forces within the global market for nasogastric tubes with future growth opportunities.

KEY INDUSTRY PLAYERS

"Investments in R&D and partnerships drive market growth"

This research finds that most of the major market players are investing in new products that would positively impact the nasogastric tube market in the long run. In order to develop such softer and more biocompatible materials and in order to make such structures more user-friendly, these companies dedicate resources to research and development. Further, healthcare providers capture’ acting as distribution channels, and acquisition of strategic partners and alliances enhances the availability of nasogastric tubes.

List of Top Nasogastric Tube Companies

• Andersen Products (U.S)
• Bard Medical (U.S)
• Bicakcilar (Turkey)
• Degania Silicone (Israel)
• Rontis Medical (Switzerland)

KEY INDUSTRY DEVELOPMENT

June 2024, the healthcare business of Medtronic released the new Flexi-Feed Nasogastric Tube. From improved material that is softer and new ways of inserting the tube into the stomach, this causes a few complications that are usually realized in normal nasogastric tubes. The introduction of this product reflects Medtronic's commitment to enhancing nutritional support solutions in clinical settings.

Five Recent Developments (2023-2025)

• 2025: Cook Medical introduced the Entuit Thrive Balloon Retention Gastrostomy Feeding Tube in the U.S., expanding its enteral nutrition portfolio with improved retention and simplified placement features.
• 2024: Manufacturers increased adoption of ENFit-compatible connectors across new nasogastric tube product lines, reaching 85% implementation to enhance patient safety and reduce misconnections.
• 2024: Several manufacturers optimized automated production processes, reducing nasogastric tube manufacturing defect rates to below 1.8%, improving quality consistency.
• 2023: Leading manufacturers expanded pediatric nasogastric tube portfolios by 30% through additional sizes and configurations designed for neonatal and pediatric care.
• 2023: Rockfield Medical Devices introduced the Mobility+ Enteral Feeding System, supporting portable enteral nutrition and compatibility with modern enteral feeding accessories used alongside nasogastric tubes.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential Applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.